PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Nagoya City University Graduate School of Medicine, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya City, Aichi, 467-8601, Japan. manabe@kklabo.gr.jp.\', \'Nagoya City University West Medical Center, Nagoya City, Aichi, Japan. manabe@kklabo.gr.jp.\', \'Nagoya City University Graduate School of Medicine, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya City, Aichi, 467-8601, Japan.\', \'Showa Pharmaceutical University, Tokyo, Japan.\', \'Yurin Hospital, Tokyo, Japan.\', \'Waseda University Regional and Inter-Regional Organization, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12879-021-06164-x
?:doi
?:hasPublicationType
?:journal
  • BMC infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34044777
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.576
?:rankingScore_hIndex
  • 80
is ?:relation_isRelatedTo_publication of
?:title
  • Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all